22: Research Delta's Nimish Mehta talks about Para IV and potential opportunities

Update: 2019-08-29

Description

The guest on today’s The Medicine Box podcast is Nimish Mehta, founder of pharma- and health-focused advisory Research Delta Advisors. Nimish’s experience in the pharma space spans more than two decades including consulting and advisory on M&A, exit, entry decisions. He joins in today to discuss what a Para IV is and he lists out any potential Para IV opportunities he foresees for specific pharma companies.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

40: The Medicine Box: Zydus Lifesciences MD Sharvil Patel on rebranding after nearly 3 decades

2022-04-2019:33

39: The Medicine Box: Cipla’s Umang Vohra on COVID-19 portfolio, upcoming drugs, US business outlook and more

2022-04-0220:58

38: The Medicine Box: Torrent Pharma eyes double digital domestic growth, cardiology key focus, says ED Aman Mehta

2022-03-2921:27

37: The Medicine Box: Home health, telemedicine here to stay? Fortis head Dr Ashutosh Raghuvanshi explains

2022-03-2321:53

36: The Medicine Box Podcast: India can become leader of innovative drugs, funding huge challenge, says Dr Reddy’s GV Prasad

2022-01-0621:18

35: The Medicine Box: JB Chemical's Nikhil Chopra on factors driving domestic pharma market’s growth

2021-12-2320:43

34: The Medicine Box: AstraZeneca’s Dr Anil Kukreja on Project Heartbeat, health tech

2021-12-1613:06

33: The Medicine Box: Tata 1MG founder Prashant Tandon on India’s health tech market

2021-12-0924:43

32: The Medicine Box: Twin Health's Jahangir Mohammad on reversing chronic diseases like diabetic

2021-12-0220:46

31: The Medicine Box: Kiran Mazumdar-Shaw on biosimilar interchangeable status for Biocon's diabetes drug

2021-11-2515:21

30: The Medicine Box: Kearney’s Saumya Krishna explains how ‘Make In India’ can fuel 4x growth in vaccines, biosimilars by 2026

2021-11-1812:30

29: The Medicine Box: Rehan Khan talks about launch of MSD India's gender-neutral HPV vaccine

2021-11-1109:42

28: Research and development in healthcare

2020-01-0223:36

27: Emerging business models in the pharmaceutical industry

2019-12-2625:19

26: public & private partnerships in healthcare

2019-12-1820:10

25: Healthcare financing models in India

2019-12-1117:22

24: Innovation in healthcare policymaking

2019-12-0423:19

22: Research Delta's Nimish Mehta talks about Para IV and potential opportunities

2019-08-2921:37

21: The Medicine Box: Wolters Kluwer CEO Shireesh Sahai talks about UpToDate app

2019-08-2218:05

20: What's trending in pharma & healthcare space

2019-08-1624:42

00:00

22: Research Delta's Nimish Mehta talks about Para IV and potential opportunities

#box-pro-ellipsis-173847235612647{-webkit-line-clamp:2;}22: Research Delta's Nimish Mehta talks about Para IV and potential opportunities

22: Research Delta's Nimish Mehta talks about Para IV and potential opportunities

CNBC-TV18

22: Research Delta's Nimish Mehta talks about Para IV and potential opportunities